Warren Chang, MD
Nephrology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Offices
- 2
- Since medical school
- 28 years
- Graduated 1998
Offices
2 locations · West Coast Kidney · North East Medical Services
Looking this up.
Hospitals listed: 052546 · 552642 · 552716 · 552878 · 752538 · Ahmc Seton Medical Center · California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · Mills-Peninsula Medical Center · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$237,697
Medicare paid this office $237,697 for 448 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 33 | $50,295 | $310 |
| Return visit (30+ min) | 164 | $42,541 | $105 |
| Critical care, first 30-74 minutes | 46 | $21,215 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $21,157 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $18,703 | $68 |
See all 18 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 33 | $50,295 | $310 |
| Return visit (30+ min) | 164 | $42,541 | $105 |
| Critical care, first 30-74 minutes | 46 | $21,215 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $21,157 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $18,703 | $68 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $12,512 | $266 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $9,957 | $142 |
| Long return visit (40+ min) | 20 | $7,174 | $149 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 39 | $6,985 | $59 |
| Hemodialysis procedure with physician evaluation | 58 | $6,606 | $62 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 154 | $5,396 | $14 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 38 | $3,679 | $46 |
| New patient visit (60+ min) | 19 | $2,894 | $152 |
| Kidney function blood test panel | 25 | $332 | $9 |
| Insertion of needle into vein for collection of blood sample | 26 | $229 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 12 | $160 | $8 |
| Total protein level, urine | 23 | $94 | $4 |
| Manual urinalysis test with examination using microscope, automated | 21 | $68 | $3 |
Who their Medicare patients are
448 Original Medicare patients in 2024. Average age 76 · Under 65 10% · 85 and older 21% · Women 48% · Also on Medicaid 43% · Health risk score 4.09. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 65% · Heart failure 52% · Coronary heart disease 48% · Atrial fibrillation 42% · Depression 23% · Stroke 22% · Dementia 20% · Cancer 16% · COPD 16%.
The office billed $662,626, Medicare allowed $313,692 and paid $237,697; for 2,392 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 448 | 2,392 | 76 | 4.09 | $662,626 | $237,697 |
| 2023 | 410 | 1,543 | 77 | 3.98 | $580,281 | $199,064 |
| 2022 | 438 | 1,773 | 75 | 4.00 | $634,362 | $210,467 |
| 2021 | 446 | 2,178 | 75 | 4.27 | $713,052 | $270,966 |
| 2020 | 473 | 2,747 | 75 | 4.23 | $742,254 | $280,187 |
| 2019 | 520 | 2,577 | 75 | 4.61 | $767,067 | $285,574 |
| 2018 | 487 | 2,500 | 74 | 4.64 | $889,173 | $284,415 |
| 2017 | 526 | 2,769 | 74 | 4.88 | $1,229,981 | $320,166 |
| 2016 | 446 | 2,544 | 75 | 4.61 | $1,208,835 | $318,234 |
| 2015 | 431 | 2,160 | 75 | 4.44 | $1,069,286 | $282,915 |
| 2014 | 436 | 2,353 | 74 | 4.43 | $1,121,754 | $291,415 |
| 2013 | 438 | 2,615 | 73 | 4.35 | $1,243,116 | $316,031 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 35 | $54,539 | $323 |
| Return visit (30+ min) | 143 | $23,468 | $72 |
| Critical care, first 30-74 minutes | 45 | $23,153 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $21,996 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $15,002 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $11,413 | $150 |
| Long return visit (40+ min) | 56 | $9,642 | $79 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $9,586 | $266 |
| Hemodialysis procedure with physician evaluation | 47 | $4,601 | $62 |
| New patient visit (60+ min) | 23 | $4,422 | $192 |
2022: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $60,456 | $322 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 149 | $27,641 | $64 |
| Return visit (30+ min) | 149 | $22,663 | $68 |
| Critical care, first 30-74 minutes | 42 | $22,225 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $16,844 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $14,363 | $173 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $10,975 | $274 |
| Hemodialysis procedure with physician evaluation | 74 | $9,247 | $64 |
| Long return visit (40+ min) | 41 | $3,041 | $29 |
| New patient visit (45+ min) | 15 | $1,665 | $111 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $740 | $46 |
2021: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $73,032 | $322 |
| Return visit (30+ min) | 159 | $40,418 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 173 | $38,701 | $64 |
| Critical care, first 30-74 minutes | 61 | $28,468 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $17,102 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $13,783 | $92 |
| Hemodialysis procedure with physician evaluation | 81 | $12,757 | $65 |
| Long return visit (40+ min) | 38 | $12,386 | $161 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $7,914 | $273 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $2,846 | $39 |
| New patient visit (60+ min) | 12 | $2,507 | $209 |
| New patient visit (45+ min) | 18 | $2,451 | $136 |
| Dialysis procedure including 1 evaluation | 11 | $2,158 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $900 | $47 |
2020: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $68,924 | $65 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | $54,419 | $260 |
| Critical care, first 30-74 minutes | 55 | $27,780 | $200 |
| Return visit (30+ min) | 134 | $23,020 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $21,831 | $183 |
| Hemodialysis procedure with physician evaluation | 89 | $21,318 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $17,410 | $96 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $7,449 | $201 |
| Long return visit (40+ min) | 27 | $5,510 | $128 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $4,382 | $104 |
| New patient visit (45+ min) | 27 | $3,642 | $135 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $2,746 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $883 | $44 |
| Short return visit (20+ min) | 20 | $862 | $41 |
2019: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | $69,074 | $257 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 199 | $46,934 | $64 |
| Critical care, first 30-74 minutes | 74 | $32,553 | $195 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $29,327 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $19,169 | $177 |
| Return visit (30+ min) | 110 | $18,611 | $91 |
| Hemodialysis procedure with physician evaluation | 93 | $17,675 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $16,439 | $93 |
| Long return visit (40+ min) | 18 | $4,323 | $135 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $3,646 | $159 |
| Short return visit (20+ min) | 35 | $2,957 | $44 |
| Dialysis procedure including 1 evaluation | 13 | $2,598 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,968 | $123 |
| New patient visit (45+ min) | 16 | $1,885 | $118 |
2018: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 52 | $58,678 | $251 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 205 | $53,678 | $64 |
| Critical care, first 30-74 minutes | 81 | $34,359 | $191 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $31,692 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $25,416 | $179 |
| Hemodialysis procedure with physician evaluation | 104 | $17,760 | $64 |
| Return visit (30+ min) | 106 | $15,507 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $12,421 | $91 |
| Long return visit (40+ min) | 20 | $4,794 | $130 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $4,537 | $168 |
| New patient visit (60+ min) | 15 | $2,744 | $183 |
| New patient visit (45+ min) | 16 | $1,988 | $124 |
| Short return visit (20+ min) | 17 | $1,140 | $46 |
2017: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 76 | $78,249 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 232 | $64,498 | $64 |
| Critical care, first 30-74 minutes | 86 | $38,569 | $195 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 54 | $29,745 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 141 | $27,827 | $173 |
| Hemodialysis procedure with physician evaluation | 114 | $22,181 | $64 |
| Return visit (30+ min) | 123 | $20,242 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $13,721 | $93 |
| New patient visit (45+ min) | 30 | $4,401 | $147 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $2,521 | $168 |
| Long return visit (40+ min) | 12 | $2,023 | $135 |
2016: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 54 | $106,387 | $256 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 188 | $39,666 | $64 |
| Critical care, first 30-74 minutes | 74 | $38,429 | $196 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $35,727 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $23,080 | $179 |
| Return visit (30+ min) | 129 | $21,630 | $92 |
| Hemodialysis procedure with physician evaluation | 80 | $13,024 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $10,768 | $93 |
| New patient visit (45+ min) | 27 | $3,616 | $134 |
| Long return visit (40+ min) | 13 | $3,524 | $136 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $2,240 | $160 |
2015: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $82,995 | $258 |
| Critical care, first 30-74 minutes | 61 | $37,110 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 183 | $32,366 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $31,132 | $218 |
| Return visit (30+ min) | 115 | $22,207 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $20,891 | $179 |
| Hemodialysis procedure with physician evaluation | 68 | $14,470 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $9,441 | $93 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $4,187 | $167 |
| Dialysis procedure including 1 evaluation | 14 | $4,143 | $78 |
| New patient visit (45+ min) | 26 | $3,578 | $138 |
| Short return visit (20+ min) | 25 | $1,827 | $61 |
| Manual urinalysis test with examination using microscope, non-automated | 11 | $46 | $4 |
2014: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | $97,279 | $254 |
| Critical care, first 30-74 minutes | 66 | $37,331 | $194 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $26,953 | $216 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 169 | $25,550 | $64 |
| Return visit (30+ min) | 111 | $23,667 | $94 |
| Hemodialysis procedure with physician evaluation | 92 | $22,159 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $18,390 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $11,058 | $92 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $2,458 | $164 |
| New patient visit (45+ min) | 18 | $2,344 | $130 |
| Short return visit (20+ min) | 29 | $2,203 | $63 |
| Short return visit (20+ min) | 17 | $1,143 | $41 |
| Manual urinalysis test with examination using microscope, non-automated | 11 | $47 | $4 |
2013: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 65 | $128,178 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 186 | $29,162 | $62 |
| Hemodialysis procedure with physician evaluation | 106 | $24,667 | $62 |
| Return visit (30+ min) | 115 | $24,093 | $91 |
| Critical care, first 30-74 minutes | 57 | $22,281 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $20,691 | $172 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $20,661 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $13,911 | $89 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 15 | $4,171 | $82 |
| New patient visit (45+ min) | 24 | $3,225 | $134 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $2,868 | $169 |
| Short return visit (20+ min) | 25 | $2,049 | $64 |
| Short return visit (20+ min) | 15 | $563 | $30 |
| Manual urinalysis test with examination using microscope, non-automated | 12 | $51 | $4 |
Medicaid work
$82,023 in 2024
Medicaid paid $82,023 for 1,159 billed services this clinician did in 2024, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 273 | $47,414 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 141 | $24,513 |
| Return visit (30+ min) | 300 | $4,681 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 107 | $4,000 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $655 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 19 | $650 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 29 | $109 |
| BODY MASS INDEX DOCD | 153 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 18 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 77 | $0 |
| Long return visit (40+ min) | 15 | $0 |
| 2024 | 1,159 | 11 | 33 | $82,023 |
| 2023 | 323 | 4 | 22 | $36,401 |
| 2022 | 198 | 3 | 18 | $13,404 |
| 2021 | 618 | 5 | 22 | $27,116 |
| 2020 | 1,085 | 6 | 29 | $36,882 |
| 2019 | 1,201 | 5 | 29 | $42,790 |
| 2018 | 600 | 4 | 29 | $15,149 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 181 | $32,132 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 96 | $2,834 |
| Return visit (30+ min) | 29 | $859 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $576 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 57 | $9,605 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 102 | $2,836 |
| Return visit (30+ min) | 39 | $962 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 168 | $21,355 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 283 | $2,839 |
| Return visit (30+ min) | 134 | $2,257 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $463 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 19 | $202 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 172 | $17,946 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 677 | $12,425 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 116 | $2,434 |
| 1ST HOSP IP/OBS HIGH 75 | 29 | $1,793 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 48 | $1,188 |
| Return visit (30+ min) | 43 | $1,096 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 215 | $21,292 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 655 | $11,571 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 226 | $6,261 |
| 1ST HOSP IP/OBS HIGH 75 | 39 | $1,885 |
| Return visit (30+ min) | 66 | $1,781 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 440 | $9,032 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 55 | $3,902 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 78 | $1,654 |
| Return visit (30+ min) | 27 | $561 |
Drugs they prescribed that Part D paid
$526,413
Pharmacies billed $526,413 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,178) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,694 generic and 484 brand-name prescriptions · $526,413 in drug cost · 18 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 188 | $187,292 | $996 |
| Velphoro | 16 | $51,041 | $3,190 |
| Lokelma | 37 | $40,567 | $1,096 |
| Jardiance | 28 | $35,294 | $1,260 |
| Eliquis | 16 | $20,715 | $1,295 |
See all 46 drugs
| Farxiga | 188 | $187,292 | $996 |
| Velphoro | 16 | $51,041 | $3,190 |
| Lokelma | 37 | $40,567 | $1,096 |
| Jardiance | 28 | $35,294 | $1,260 |
| Eliquis | 16 | $20,715 | $1,295 |
| Veltassa | 19 | $15,593 | $821 |
| Kerendia | 13 | $14,508 | $1,116 |
| Dapagliflozin | 22 | $12,449 | $566 |
| Prosol | 86 | $11,859 | $138 |
| Sevelamer Carbonate | 35 | $9,595 | $274 |
| Cinacalcet | 31 | $7,155 | $231 |
| Midodrine | 26 | $6,086 | $234 |
| Hydralazine | 177 | $2,909 | $16 |
| Labetalol | 56 | $2,630 | $47 |
| Sodium Polystyrene Sulfonate | 23 | $2,050 | $89 |
| Calcitriol | 86 | $1,994 | $23 |
| Calcium Acetate | 16 | $1,875 | $117 |
| Losartan | 124 | $1,660 | $13 |
| Bumetanide | 32 | $1,524 | $48 |
| Amlodipine Besylate | 174 | $1,498 | $9 |
| Atorvastatin | 48 | $1,057 | $22 |
| Tamsulosin | 31 | $961 | $31 |
| Furosemide | 89 | $872 | $10 |
| Chlorthalidone | 48 | $861 | $18 |
| Metoprolol | 31 | $563 | $18 |
| Valsartan | 21 | $560 | $27 |
| Nifedipine Er | 22 | $536 | $24 |
| Irbesartan | 40 | $519 | $13 |
| Spironolactone | 37 | $441 | $12 |
| Omeprazole | 16 | $363 | $23 |
| Carvedilol | 22 | $339 | $15 |
| Torsemide | 17 | $285 | $17 |
| Benazepril | 18 | $282 | $16 |
| Clonidine | 16 | $275 | $17 |
| Hydrochlorothiazide | 63 | $249 | $4 |
| Pantoprazole | 22 | $245 | $11 |
| Lisinopril | 50 | $237 | $5 |
| Nystatin | 13 | $235 | $18 |
| Allopurinol | 17 | $231 | $14 |
| Colchicine | 17 | $213 | $13 |
| Prednisone | 25 | $212 | $8 |
| Metoprolol | 16 | $172 | $11 |
| Potassium Chloride | 14 | $150 | $11 |
| Minoxidil | 11 | $121 | $11 |
| Atenolol | 11 | $120 | $11 |
| Trazodone | 15 | $70 | $5 |
Year by year
| 2024 | 2,178 | 319 | 0% (0) | 22% | $526,413 |
| 2023 | 1,949 | 289 | 0% (0) | None | $409,074 |
| 2022 | 1,714 | 269 | 0% (0) | None | $259,153 |
| 2021 | 1,775 | 252 | None | None | $268,331 |
| 2020 | 1,581 | 216 | None | None | $219,985 |
| 2019 | 1,551 | 223 | None | None | $203,895 |
| 2018 | 1,625 | 230 | 2% (25) | None | $232,444 |
| 2017 | 1,886 | 223 | 2% (30) | None | $464,422 |
| 2016 | 2,311 | 225 | 1% (31) | 33% | $525,505 |
| 2015 | 2,317 | 218 | 1% (31) | None | $541,353 |
| 2014 | 2,266 | 240 | 2% (46) | 40% | $536,212 |
| 2013 | 3,427 | 262 | 4% (139) | 33% | $623,314 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Farxiga | 180 | $164,002 | $911 |
| Lokelma | 33 | $32,962 | $999 |
| Prosol | 153 | $19,824 | $130 |
| Jardiance | 13 | $19,470 | $1,498 |
| Eliquis | 18 | $16,448 | $914 |
| Veltassa | 16 | $9,104 | $569 |
| Cinacalcet | 26 | $7,565 | $291 |
| Sevelamer Carbonate | 33 | $6,778 | $205 |
| Bumetanide | 39 | $4,166 | $107 |
| Sodium Polystyrene Sulfonate | 31 | $3,773 | $122 |
| Hydralazine | 135 | $3,483 | $26 |
| Midodrine | 14 | $2,928 | $209 |
| Irbesartan | 68 | $2,876 | $42 |
| Labetalol | 51 | $2,819 | $55 |
| Calcitriol | 92 | $2,643 | $29 |
| Valsartan | 36 | $2,576 | $72 |
| Tacrolimus | 16 | $2,526 | $158 |
| Calcium Acetate | 14 | $2,220 | $159 |
| Amlodipine Besylate | 144 | $2,141 | $15 |
| Chlorthalidone | 81 | $1,896 | $23 |
| Losartan | 74 | $1,563 | $21 |
| Torsemide | 29 | $1,124 | $39 |
| Furosemide | 65 | $691 | $11 |
| Metolazone | 13 | $619 | $48 |
| Nifedipine Er | 18 | $603 | $34 |
| Carvedilol | 21 | $478 | $23 |
| Lisinopril | 48 | $462 | $10 |
| Allopurinol | 22 | $445 | $20 |
| Spironolactone | 24 | $425 | $18 |
| Atorvastatin | 32 | $418 | $13 |
| Metoprolol | 18 | $412 | $23 |
| Tamsulosin | 17 | $398 | $23 |
| Pantoprazole | 15 | $301 | $20 |
| Clonidine | 13 | $271 | $21 |
| Hydrochlorothiazide | 36 | $197 | $5 |
| Metoprolol | 21 | $159 | $8 |
| Colchicine | 12 | $142 | $12 |
| Prednisone | 15 | $140 | $9 |
| Potassium Chloride | 11 | $113 | $10 |
| Cephalexin | 12 | $50 | $4 |
2022: 33 drugs
| Farxiga | 83 | $69,875 | $842 |
| Cinacalcet | 33 | $20,195 | $612 |
| Prosol | 112 | $15,549 | $139 |
| Jardiance | 11 | $13,204 | $1,200 |
| Velphoro | 11 | $12,598 | $1,145 |
| Lokelma | 15 | $12,437 | $829 |
| Sevelamer Carbonate | 34 | $9,059 | $266 |
| Eliquis | 12 | $6,792 | $566 |
| Hydralazine | 138 | $4,571 | $33 |
| Bumetanide | 44 | $3,650 | $83 |
| Irbesartan | 55 | $3,595 | $65 |
| Labetalol | 63 | $3,459 | $55 |
| Chlorthalidone | 106 | $2,919 | $28 |
| Calcitriol | 98 | $2,577 | $26 |
| Valsartan | 29 | $2,512 | $87 |
| Sodium Polystyrene Sulfonate | 27 | $2,480 | $92 |
| Losartan | 77 | $1,389 | $18 |
| Calcium Acetate | 18 | $1,334 | $74 |
| Tacrolimus | 21 | $1,118 | $53 |
| Amlodipine Besylate | 126 | $948 | $8 |
| Midodrine | 21 | $945 | $45 |
| Torsemide | 12 | $733 | $61 |
| Furosemide | 39 | $543 | $14 |
| Carvedilol | 33 | $521 | $16 |
| Lisinopril | 61 | $505 | $8 |
| Metoprolol | 27 | $478 | $18 |
| Spironolactone | 17 | $405 | $24 |
| Clonidine | 19 | $322 | $17 |
| Allopurinol | 21 | $318 | $15 |
| Isosorbide Mononitrate Er | 14 | $265 | $19 |
| Atorvastatin | 33 | $225 | $7 |
| Prednisone | 23 | $158 | $7 |
| Hydrochlorothiazide | 11 | $40 | $4 |
2021: 35 drugs
| Cinacalcet | 33 | $36,343 | $1,101 |
| Clinolipid | 102 | $28,542 | $280 |
| Auryxia | 11 | $25,158 | $2,287 |
| Velphoro | 11 | $17,100 | $1,555 |
| Prosol | 100 | $16,896 | $169 |
| Eliquis | 19 | $9,812 | $516 |
| Sevelamer Carbonate | 48 | $9,714 | $202 |
| Farxiga | 14 | $9,657 | $690 |
| Lokelma | 11 | $7,847 | $713 |
| Hydralazine | 172 | $4,564 | $27 |
| Bumetanide | 55 | $4,223 | $77 |
| Labetalol | 76 | $4,087 | $54 |
| Calcitriol | 110 | $3,870 | $35 |
| Clinisol | 21 | $3,470 | $165 |
| Torsemide | 29 | $2,345 | $81 |
| Febuxostat | 14 | $1,842 | $132 |
| Tacrolimus | 24 | $1,836 | $77 |
| Valsartan | 22 | $1,768 | $80 |
| Irbesartan | 31 | $1,433 | $46 |
| Losartan | 93 | $1,297 | $14 |
| Calcium Acetate | 16 | $1,247 | $78 |
| Chlorthalidone | 38 | $1,055 | $28 |
| Amlodipine Besylate | 106 | $989 | $9 |
| Mycophenolate Mofetil | 16 | $775 | $48 |
| Metoprolol | 19 | $606 | $32 |
| Allopurinol | 21 | $434 | $21 |
| Furosemide | 35 | $408 | $12 |
| Carvedilol | 31 | $321 | $10 |
| Spironolactone | 15 | $320 | $21 |
| Prednisone | 40 | $315 | $8 |
| Clonidine | 20 | $306 | $15 |
| Lisinopril | 39 | $297 | $8 |
| Atorvastatin | 18 | $211 | $12 |
| Gabapentin | 13 | $117 | $9 |
| Hydrochlorothiazide | 13 | $31 | $2 |
2020: 33 drugs
| Prosol | 168 | $35,458 | $211 |
| Veltassa | 32 | $24,948 | $780 |
| Auryxia | 11 | $17,492 | $1,590 |
| Sevelamer Carbonate | 51 | $12,949 | $254 |
| Cinacalcet | 16 | $11,355 | $710 |
| Clinisol | 60 | $9,589 | $160 |
| Clinolipid | 25 | $6,436 | $257 |
| Labetalol | 73 | $4,063 | $56 |
| Calcitriol | 109 | $3,894 | $36 |
| Hydralazine | 139 | $2,759 | $20 |
| Bumetanide | 41 | $2,743 | $67 |
| Calcium Acetate | 16 | $1,821 | $114 |
| Tacrolimus | 26 | $1,594 | $61 |
| Intralipid | 11 | $1,550 | $141 |
| Gengraf | 12 | $1,392 | $116 |
| Irbesartan | 20 | $1,119 | $56 |
| Losartan | 83 | $1,034 | $12 |
| Valsartan | 14 | $914 | $65 |
| Midodrine | 14 | $794 | $57 |
| Chlorthalidone | 19 | $781 | $41 |
| Terazosin | 11 | $671 | $61 |
| Bisoprolol | 11 | $656 | $60 |
| Amlodipine Besylate | 69 | $571 | $8 |
| Furosemide | 47 | $412 | $9 |
| Atorvastatin | 13 | $322 | $25 |
| Spironolactone | 12 | $302 | $25 |
| Lisinopril | 38 | $280 | $7 |
| Prednisone | 17 | $237 | $14 |
| Carvedilol | 23 | $198 | $9 |
| Alendronate | 12 | $171 | $14 |
| Gabapentin | 18 | $171 | $9 |
| Tamsulosin | 16 | $129 | $8 |
| Hydrochlorothiazide | 17 | $126 | $7 |
2019: 31 drugs
| Sevelamer Carbonate | 56 | $45,359 | $810 |
| Veltassa | 21 | $15,209 | $724 |
| Clinisol | 88 | $11,879 | $135 |
| Prosol | 70 | $11,400 | $163 |
| Labetalol | 116 | $5,409 | $47 |
| Dextrose in Water | 28 | $4,337 | $155 |
| Calcitriol | 131 | $3,786 | $29 |
| Humalog | 12 | $3,450 | $288 |
| Hydralazine | 102 | $1,570 | $15 |
| Valsartan | 21 | $1,336 | $64 |
| Midodrine | 21 | $1,202 | $57 |
| Chlorthalidone | 21 | $1,164 | $55 |
| Bumetanide | 28 | $1,139 | $41 |
| Tacrolimus | 23 | $831 | $36 |
| Losartan | 114 | $811 | $7 |
| Mycophenolate Mofetil | 11 | $798 | $73 |
| Amlodipine Besylate | 81 | $735 | $9 |
| Nifedipine Er | 30 | $711 | $24 |
| Terazosin | 16 | $592 | $37 |
| Furosemide | 40 | $341 | $9 |
| Tamsulosin | 17 | $323 | $19 |
| Pantoprazole | 19 | $242 | $13 |
| Atorvastatin | 17 | $225 | $13 |
| Clonidine | 16 | $214 | $13 |
| Prednisone | 17 | $198 | $12 |
| Carvedilol | 17 | $192 | $11 |
| Lisinopril | 27 | $175 | $6 |
| Allopurinol | 12 | $169 | $14 |
| Hydrochlorothiazide | 25 | $136 | $5 |
| Gabapentin | 15 | $135 | $9 |
| Benazepril | 12 | $103 | $9 |
2018: 39 drugs
| Renvela | 30 | $58,193 | $1,940 |
| Sevelamer Carbonate | 54 | $47,370 | $877 |
| Intralipid | 54 | $12,445 | $230 |
| Prosol | 78 | $10,502 | $135 |
| Veltassa | 14 | $8,496 | $607 |
| Aranesp | 11 | $8,478 | $771 |
| Labetalol | 86 | $4,495 | $52 |
| Calcitriol | 148 | $3,287 | $22 |
| Humalog | 11 | $3,204 | $291 |
| Dextrose in Water | 13 | $2,025 | $156 |
| Mycophenolate Mofetil | 17 | $1,929 | $113 |
| Tacrolimus | 25 | $1,702 | $68 |
| Valsartan | 25 | $1,043 | $42 |
| Losartan | 132 | $1,030 | $8 |
| Hydrocodone-Acetaminophen | 18 | $984 | $55 |
| Hydralazine | 69 | $981 | $14 |
| Bumetanide | 31 | $979 | $32 |
| Midodrine | 18 | $869 | $48 |
| Chlorthalidone | 14 | $677 | $48 |
| Amlodipine Besylate | 97 | $570 | $6 |
| Tamsulosin | 17 | $506 | $30 |
| Warfarin | 14 | $458 | $33 |
| Acarbose | 13 | $347 | $27 |
| Carvedilol | 38 | $343 | $9 |
| Torsemide | 19 | $310 | $16 |
| Nifedipine Er | 15 | $295 | $20 |
| Terazosin | 13 | $280 | $22 |
| Allopurinol | 13 | $239 | $18 |
| Atorvastatin | 18 | $229 | $13 |
| Spironolactone | 12 | $229 | $19 |
| Gabapentin | 11 | $218 | $20 |
| Prednisone | 31 | $217 | $7 |
| Hydrochlorothiazide | 36 | $206 | $6 |
| Lisinopril | 52 | $187 | $4 |
| Pantoprazole | 19 | $140 | $7 |
| Metoprolol | 21 | $119 | $6 |
| Alendronate | 14 | $97 | $7 |
| Benazepril | 12 | $81 | $7 |
| Furosemide | 25 | $79 | $3 |
2017: 38 drugs
| Renvela | 136 | $193,648 | $1,424 |
| Sensipar | 98 | $139,747 | $1,426 |
| Prosol | 116 | $20,967 | $181 |
| Renagel | 19 | $12,109 | $637 |
| Aranesp | 12 | $9,272 | $773 |
| Labetalol | 94 | $4,590 | $49 |
| Veltassa | 11 | $4,578 | $416 |
| Calcitriol | 193 | $4,416 | $23 |
| Bumetanide | 33 | $2,670 | $81 |
| Calcium Acetate | 21 | $1,505 | $72 |
| Mycophenolate Mofetil | 15 | $1,374 | $92 |
| Valsartan | 28 | $1,318 | $47 |
| Midodrine | 30 | $1,021 | $34 |
| Tacrolimus | 22 | $844 | $38 |
| Losartan | 117 | $782 | $7 |
| Hydralazine | 51 | $766 | $15 |
| Hydrocodone-Acetaminophen | 19 | $494 | $26 |
| Acarbose | 14 | $463 | $33 |
| Amlodipine Besylate | 106 | $411 | $4 |
| Torsemide | 32 | $359 | $11 |
| Levothyroxine | 16 | $345 | $22 |
| Atorvastatin | 11 | $343 | $31 |
| Doxazosin Mesylate | 12 | $342 | $29 |
| Allopurinol | 28 | $336 | $12 |
| Omeprazole | 22 | $301 | $14 |
| Lisinopril | 63 | $298 | $5 |
| Terazosin | 18 | $202 | $11 |
| Furosemide | 56 | $190 | $3 |
| Metoprolol | 25 | $177 | $7 |
| Warfarin | 13 | $173 | $13 |
| Prednisone | 16 | $173 | $11 |
| Carvedilol | 30 | $146 | $5 |
| Hydrochlorothiazide | 25 | $134 | $5 |
| Spironolactone | 16 | $117 | $7 |
| Clonidine | 17 | $110 | $6 |
| Famotidine | 11 | $84 | $8 |
| Minoxidil | 16 | $63 | $4 |
| Benazepril | 13 | $54 | $4 |
2016: 39 drugs
| Renvela | 199 | $270,091 | $1,357 |
| Sensipar | 94 | $109,066 | $1,160 |
| Prosol | 159 | $47,897 | $301 |
| Velphoro | 11 | $14,284 | $1,299 |
| Aranesp | 14 | $10,493 | $750 |
| Renagel | 13 | $8,233 | $633 |
| Dextrose in Water | 87 | $4,990 | $57 |
| Calcium Acetate | 40 | $3,739 | $93 |
| Calcitriol | 174 | $3,526 | $20 |
| Labetalol | 108 | $3,097 | $29 |
| Bumetanide | 29 | $2,037 | $70 |
| Nifedipine Er | 25 | $1,228 | $49 |
| Valsartan | 39 | $1,122 | $29 |
| Midodrine | 31 | $1,009 | $33 |
| Losartan | 131 | $819 | $6 |
| Mycophenolate Mofetil | 16 | $790 | $49 |
| Hydralazine | 34 | $658 | $19 |
| Hydrocodone-Acetaminophen | 19 | $648 | $34 |
| Amlodipine Besylate | 142 | $614 | $4 |
| Torsemide | 38 | $588 | $15 |
| Atorvastatin | 39 | $527 | $14 |
| Tamsulosin | 29 | $481 | $17 |
| Omeprazole | 58 | $442 | $8 |
| Lisinopril | 68 | $391 | $6 |
| Acarbose | 13 | $383 | $29 |
| Furosemide | 78 | $356 | $5 |
| Allopurinol | 29 | $284 | $10 |
| Carvedilol | 49 | $283 | $6 |
| Clonidine | 32 | $206 | $6 |
| Clopidogrel | 18 | $183 | $10 |
| Hydrochlorothiazide | 43 | $183 | $4 |
| Levofloxacin | 11 | $182 | $17 |
| Warfarin | 20 | $168 | $8 |
| Valsartan-Hydrochlorothiazide | 13 | $157 | $12 |
| Benazepril | 21 | $155 | $7 |
| Metoprolol | 16 | $148 | $9 |
| Minoxidil | 17 | $112 | $7 |
| Lovastatin | 16 | $84 | $5 |
| Atenolol | 15 | $37 | $2 |
2015: 48 drugs
| Renvela | 302 | $305,058 | $1,010 |
| Sensipar | 84 | $98,088 | $1,168 |
| Prosol | 121 | $33,025 | $273 |
| Aranesp | 15 | $10,717 | $714 |
| Lantus | 24 | $9,085 | $379 |
| Renagel | 12 | $6,672 | $556 |
| Advair Diskus | 13 | $3,983 | $306 |
| Diovan | 11 | $3,729 | $339 |
| Ranexa | 13 | $3,704 | $285 |
| Labetalol | 61 | $3,015 | $49 |
| Omega-3 Acid Ethyl Esters | 13 | $2,956 | $227 |
| Calcium Acetate | 43 | $2,858 | $66 |
| Calcitriol | 148 | $2,376 | $16 |
| Dextrose in Water | 52 | $2,308 | $44 |
| Nifedipine Er | 24 | $1,511 | $63 |
| Valsartan | 33 | $1,164 | $35 |
| Tamsulosin | 47 | $913 | $19 |
| Torsemide | 39 | $838 | $21 |
| Sodium Polystyrene Sulfonate | 11 | $827 | $75 |
| Losartan | 143 | $750 | $5 |
| Amlodipine Besylate | 123 | $650 | $5 |
| Atorvastatin | 55 | $635 | $12 |
| Hydralazine | 34 | $598 | $18 |
| Potassium Chloride | 14 | $541 | $39 |
| Hydrocodone-Acetaminophen | 21 | $504 | $24 |
| Midodrine | 13 | $439 | $34 |
| Omeprazole | 52 | $433 | $8 |
| Lisinopril | 59 | $325 | $6 |
| Carvedilol | 66 | $314 | $5 |
| Chlorthalidone | 12 | $292 | $24 |
| Furosemide | 47 | $230 | $5 |
| Clopidogrel | 27 | $218 | $8 |
| Pantoprazole | 18 | $207 | $12 |
| Allopurinol | 19 | $201 | $11 |
| Isosorbide Mononitrate Er | 15 | $201 | $13 |
| Minoxidil | 25 | $197 | $8 |
| Clonidine | 29 | $181 | $6 |
| Hydrochlorothiazide | 41 | $177 | $4 |
| Metoprolol | 25 | $138 | $6 |
| Terazosin | 22 | $136 | $6 |
| Alendronate | 12 | $132 | $11 |
| Finasteride | 14 | $123 | $9 |
| Simvastatin | 15 | $81 | $5 |
| Atenolol | 24 | $74 | $3 |
| Metoclopramide | 16 | $74 | $5 |
| Lovastatin | 12 | $70 | $6 |
| Benazepril | 15 | $63 | $4 |
| Ciprofloxacin | 15 | $55 | $4 |
2014: 53 drugs
| Renvela | 258 | $246,399 | $955 |
| Sensipar | 92 | $79,997 | $870 |
| Prosol | 94 | $25,861 | $275 |
| Fosrenol | 13 | $15,115 | $1,163 |
| Renagel | 17 | $14,087 | $829 |
| Lantus | 33 | $10,245 | $310 |
| Diovan | 37 | $9,739 | $263 |
| Sevelamer Carbonate | 11 | $8,064 | $733 |
| Lovaza | 12 | $4,599 | $383 |
| Advair Diskus | 13 | $4,292 | $330 |
| Calcium Acetate | 37 | $3,460 | $94 |
| Colcrys | 12 | $2,990 | $249 |
| Calcitriol | 128 | $2,832 | $22 |
| Labetalol | 50 | $2,788 | $56 |
| Dextrose in Water | 48 | $2,040 | $43 |
| Benicar | 14 | $1,705 | $122 |
| Nifedipine Er | 17 | $1,647 | $97 |
| Torsemide | 43 | $1,064 | $25 |
| Repaglinide | 15 | $1,033 | $69 |
| Hydralazine | 42 | $913 | $22 |
| Amlodipine Besylate | 132 | $905 | $7 |
| Losartan | 83 | $792 | $10 |
| Sodium Polystyrene Sulfonate | 16 | $720 | $45 |
| Hydrocodone-Acetaminophen | 30 | $599 | $20 |
| Atorvastatin | 36 | $501 | $14 |
| Lisinopril | 84 | $482 | $6 |
| Tamsulosin | 34 | $442 | $13 |
| Omeprazole | 30 | $418 | $14 |
| Gentamicin Sulfate | 13 | $380 | $29 |
| Metoprolol | 45 | $370 | $8 |
| Clonidine | 49 | $331 | $7 |
| Carvedilol | 37 | $291 | $8 |
| Isosorbide Mononitrate Er | 13 | $278 | $21 |
| Finasteride | 15 | $270 | $18 |
| Potassium Chloride | 14 | $249 | $18 |
| Clopidogrel | 25 | $247 | $10 |
| Benazepril | 41 | $243 | $6 |
| Hydrochlorothiazide | 60 | $219 | $4 |
| Furosemide | 42 | $193 | $5 |
| Hydroxyzine | 11 | $135 | $12 |
| Alendronate | 13 | $124 | $10 |
| Allopurinol | 24 | $106 | $4 |
| Simvastatin | 11 | $103 | $9 |
| Metoclopramide | 17 | $100 | $6 |
| Pantoprazole | 14 | $98 | $7 |
| Terazosin | 12 | $85 | $7 |
| Prednisone | 11 | $78 | $7 |
| Zolpidem | 18 | $76 | $4 |
| Lovastatin | 12 | $70 | $6 |
| Ciprofloxacin | 12 | $53 | $4 |
| Atenolol | 12 | $52 | $4 |
| Fluoxetine | 11 | $47 | $4 |
| Ranitidine | 11 | $35 | $3 |
2013: 77 drugs
| Renvela | 251 | $203,676 | $811 |
| Sensipar | 72 | $45,126 | $627 |
| Renagel | 35 | $42,236 | $1,207 |
| Prosol | 136 | $31,199 | $229 |
| Fosrenol | 22 | $23,367 | $1,062 |
| Diovan | 56 | $11,442 | $204 |
| Advair Diskus | 25 | $7,736 | $309 |
| Cymbalta | 14 | $7,010 | $501 |
| Nexium | 14 | $5,035 | $360 |
| Labetalol | 93 | $4,733 | $51 |
| Lantus | 19 | $4,092 | $215 |
| Nifedipine Er | 33 | $2,605 | $79 |
| Lovaza | 11 | $2,285 | $208 |
| Calcitriol | 84 | $2,161 | $26 |
| Crestor | 12 | $2,056 | $171 |
| Multaq | 12 | $1,934 | $161 |
| Amlodipine Besylate | 228 | $1,915 | $8 |
| Fenofibrate | 21 | $1,747 | $83 |
| Metoprolol | 40 | $1,722 | $43 |
| Hydrocodone-Acetaminophen | 116 | $1,722 | $15 |
| Clopidogrel | 28 | $1,720 | $61 |
| Calcium Acetate | 21 | $1,514 | $72 |
| Hydralazine | 52 | $1,491 | $29 |
| Atorvastatin | 45 | $1,461 | $32 |
| Benicar | 12 | $1,362 | $113 |
| Escitalopram | 24 | $1,187 | $49 |
| Losartan | 53 | $1,180 | $22 |
| Torsemide | 40 | $1,023 | $26 |
| Gabapentin | 55 | $863 | $16 |
| Lisinopril | 111 | $835 | $8 |
| Metolazone | 19 | $814 | $43 |
| Quetiapine | 14 | $774 | $55 |
| Amlodipine Besylate-Benazepril | 22 | $704 | $32 |
| Simvastatin | 58 | $652 | $11 |
| Nifedical Xl | 15 | $629 | $42 |
| Levothyroxine | 76 | $629 | $8 |
| Spironolactone | 21 | $627 | $30 |
| Warfarin | 55 | $563 | $10 |
| Metoprolol | 59 | $555 | $9 |
| Losartan-Hydrochlorothiazide | 30 | $545 | $18 |
| Nifediac Cc | 11 | $542 | $49 |
| Carvedilol | 50 | $541 | $11 |
| Tamsulosin | 33 | $529 | $16 |
| Midodrine | 15 | $460 | $31 |
| Furosemide | 80 | $438 | $5 |
| Omeprazole | 26 | $418 | $16 |
| Klor-Con 10 | 11 | $407 | $37 |
| Lidocaine-Prilocaine | 19 | $405 | $21 |
| Pantoprazole | 25 | $404 | $16 |
| Clonidine | 49 | $401 | $8 |
| Benazepril | 61 | $352 | $6 |
| Finasteride | 11 | $340 | $31 |
| Fluticasone Propionate | 17 | $331 | $19 |
| Potassium Chloride | 17 | $303 | $18 |
| Klor-Con M20 | 15 | $274 | $18 |
| Testosterone Cypionate | 13 | $270 | $21 |
| Pravastatin | 11 | $262 | $24 |
| Alendronate | 24 | $232 | $10 |
| Fluphenazine | 12 | $225 | $19 |
| Hydrochlorothiazide | 59 | $221 | $4 |
| Zolpidem | 33 | $201 | $6 |
| Minoxidil | 16 | $186 | $12 |
| Bumetanide | 11 | $186 | $17 |
| Acyclovir | 12 | $148 | $12 |
| Hydroxyzine | 11 | $146 | $13 |
| Triamterene-Hctz | 11 | $145 | $13 |
| Lorazepam | 16 | $129 | $8 |
| Glipizide | 21 | $129 | $6 |
| Azithromycin | 11 | $124 | $11 |
| Terazosin | 12 | $108 | $9 |
| Allopurinol | 19 | $100 | $5 |
| Ciprofloxacin | 18 | $84 | $5 |
| Atenolol | 18 | $74 | $4 |
| Tramadol | 11 | $73 | $7 |
| Famotidine | 12 | $60 | $5 |
| Prednisone | 11 | $54 | $5 |
| Ranitidine | 11 | $52 | $5 |
Money from drug and device companies
$2,086 in 2025
| 2025 | 20 | 80 | None | $2,086 |
| 2024 | 18 | 60 | None | $1,440 |
| 2023 | 12 | 48 | None | $1,138 |
| 2022 | 8 | 22 | None | $384 |
| 2021 | 6 | 35 | None | $659 |
| 2020 | 4 | 21 | None | $377 |
| 2019 | 4 | 27 | None | $460 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Farxiga | $318 | 12 payments
|
| Novo Nordisk | Wegovy | $294 | 14 payments
|
| Novartis Pharmaceuticals | Fabhalta | $223 | 8 payments
|
| Mallinckrodt Hospital Products | Acthar | $154 | 7 payments
|
| Calliditas Therapeutics US | Tarpeyo | $144 | 6 payments
|
| Vantive US Healthcare | Renal - Pd | $141 | 1 payment
|
See all 79 published payments
| Amgen | Meals · 2025-12-19 | Tavneos | $22 |
| Amgen | Meals · 2025-12-18 | Tavneos | $25 |
| Vantive US Healthcare | Meals · 2025-12-15 | Renal - Pd | $141 |
| Calliditas Therapeutics US | Meals · 2025-12-15 | Tarpeyo | $24 |
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Fabhalta | $33 |
| ANI Pharmaceuticals | Meals · 2025-12-11 | Purified Cortrophin Gel | $29 |
| Apellis Pharmaceuticals | Meals · 2025-12-09 | Empaveli | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-05 | Farxiga | $29 |
| Travere Therapeutics | Meals · 2025-12-05 | None | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-13 | Kerendia | $24 |
| Novo Nordisk | Meals · 2025-11-06 | Wegovy | $12 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Fabhalta | $25 |
| Novo Nordisk | Meals · 2025-10-29 | Wegovy | $16 |
| Scpharmaceuticals | Meals · 2025-10-23 | Furoscix | $30 |
| Novo Nordisk | Meals · 2025-10-16 | Wegovy | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-03 | Kerendia | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-02 | Fabhalta | $32 |
| Aurinia Pharma U.S. | Meals · 2025-09-26 | Lupkynis | $27 |
| Harrow Eye | Meals · 2025-09-25 | None | $14 |
| Novartis Pharmaceuticals | Meals · 2025-09-19 | Vanrafia | $25 |
| Novartis Pharmaceuticals | Meals · 2025-09-16 | Fabhalta | $26 |
| Otsuka America Pharmaceutical | Meals · 2025-09-11 | Jynarque | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-30 | Farxiga | $24 |
| Ardelyx | Meals · 2025-08-28 | Ibsrela | $24 |
| Ardelyx | Meals · 2025-08-22 | Ibsrela | $23 |
| ANI Pharmaceuticals | Meals · 2025-08-14 | Purified Cortrophin Gel | $35 |
| Mallinckrodt Hospital Products | Meals · 2025-08-09 | Acthar | $34 |
| Akebia Therapeutics | Meals · 2025-08-07 | Vafseo | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-01 | Lokelma | $30 |
| Mallinckrodt Hospital Products | Meals · 2025-07-25 | Acthar | $9 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-24 | Jardiance | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-07-18 | Acthar | $27 |
| Amgen | Meals · 2025-07-18 | Tavneos | $26 |
| Mallinckrodt Hospital Products | Meals · 2025-06-14 | Acthar | $8 |
| Mallinckrodt Hospital Products | Meals · 2025-06-14 | Acthar | $12 |
| Novo Nordisk | Meals · 2025-06-11 | Wegovy | $3 |
| Novo Nordisk | Meals · 2025-06-11 | Wegovy | $10 |
| Ardelyx | Meals · 2025-06-05 | Ibsrela | $28 |
| Amgen | Meals · 2025-05-30 | Tavneos | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-23 | Lokelma | $28 |
| Calliditas Therapeutics US | Meals · 2025-05-23 | Tarpeyo | $5 |
| Calliditas Therapeutics US | Meals · 2025-05-23 | Tarpeyo | $8 |
| Calliditas Therapeutics US | Meals · 2025-05-23 | Tarpeyo | $34 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-16 | Kerendia | $34 |
| Calliditas Therapeutics US | Meals · 2025-05-16 | Tarpeyo | $37 |
| Novo Nordisk | Meals · 2025-05-14 | Wegovy | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-09 | Lokelma | $28 |
| Novo Nordisk | Meals · 2025-05-08 | Wegovy | $23 |
| Novo Nordisk | Meals · 2025-05-06 | Wegovy | $11 |
| Mallinckrodt Hospital Products | Meals · 2025-05-02 | Acthar | $36 |
| Novo Nordisk | Meals · 2025-04-14 | Wegovy | $11 |
| Otsuka America Pharmaceutical | Meals · 2025-04-01 | Jynarque | $26 |
| Novartis Pharmaceuticals | Meals · 2025-03-28 | Fabhalta | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-22 | Farxiga | $24 |
| Travere Therapeutics | Meals · 2025-03-18 | None | $34 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-14 | None | $27 |
| ANI Pharmaceuticals | Meals · 2025-03-13 | Purified Cortrophin Gel | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-08 | Farxiga | $34 |
| Novo Nordisk | Meals · 2025-03-06 | Ozempic | $8 |
| Novo Nordisk | Meals · 2025-03-06 | Ozempic | $11 |
| Abiomed | Meals · 2025-02-27 | None | $31 |
| Novo Nordisk | Meals · 2025-02-25 | Ozempic | $23 |
| Novo Nordisk | Meals · 2025-02-24 | Wegovy | $122 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-22 | Lokelma | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-22 | Farxiga | $23 |
| Novo Nordisk | Meals · 2025-02-18 | Ozempic | $15 |
| Otsuka America Pharmaceutical | Meals · 2025-02-18 | Jynarque | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $32 |
| Novartis Pharmaceuticals | Meals · 2025-02-07 | Fabhalta | $28 |
| Travere Therapeutics | Meals · 2025-02-07 | None | $36 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-01 | Farxiga | $35 |
| Mallinckrodt Hospital Products | Meals · 2025-01-31 | Acthar | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-25 | Farxiga | $28 |
| Aurinia Pharma U.S. | Meals · 2025-01-24 | Lupkynis | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-01-17 | Jynarque | $23 |
| Calliditas Therapeutics US | Meals · 2025-01-16 | Tarpeyo | $36 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-14 | Farxiga | $26 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Fabhalta | $28 |
| Amgen | Meals · 2025-01-10 | Tavneos | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,440
| AstraZeneca Pharmaceuticals LP | Farxiga | $258 | 11 payments
|
| Mallinckrodt Hospital Products | Acthar | $169 | 6 payments
|
| Novartis Pharmaceuticals | Fabhalta | $124 | 4 payments
|
| Novo Nordisk | Ozempic | $120 | 6 payments
|
| Calliditas Therapeutics US | Tarpeyo | $107 | 5 payments
|
| Amgen | Krystexxa | $104 | 5 payments
|
| Otsuka America Pharmaceutical | Jynarque | $75 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $68 | 3 payments
|
| Vifor Pharma | Veltassa | $65 | 2 payments
|
| OPKO Pharmaceuticals | Rayaldee | $59 | 3 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $56 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $53 | 2 payments
|
| Lilly USA | Jardiance | $49 | 2 payments
|
| Travere Therapeutics | None | $35 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Livtencity | $28 | 1 payment
|
| Ardelyx | Ibsrela | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
2023: $1,138
| AstraZeneca Pharmaceuticals LP | Farxiga | $234 | 10 payments
|
| Amgen | Aranesp | $230 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $212 | 11 payments
|
| Mallinckrodt Hospital Products | Acthar | $135 | 6 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $76 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $69 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $51 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $40 | 2 payments
|
| Travere Therapeutics | None | $29 | 1 payment
|
| CMP Pharma | Carospir | $23 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $23 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
2022: $384
| AstraZeneca Pharmaceuticals LP | Farxiga | $117 | 6 payments
|
| Otsuka America Pharmaceutical | Jynarque | $69 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $57 | 3 payments
|
| Vifor Pharma | Veltassa | $57 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $27 | 2 payments
|
| Amgen | Parsabiv | $23 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $15 | 1 payment
|
2021: $659
| AstraZeneca Pharmaceuticals LP | Lokelma | $186 | 8 payments
|
| Amgen | Parsabiv | $158 | 6 payments
|
| Fresenius USA Marketing | Velphoro | $149 | 9 payments
|
| Otsuka America Pharmaceutical | Jynarque | $108 | 5 payments
|
| Vifor Pharma | Veltassa | $45 | 2 payments
|
| Daiichi Sankyo | Injectafer | $13 | 1 payment
|
2020: $377
| AstraZeneca Pharmaceuticals LP | Lokelma | $260 | 15 payments
|
| Otsuka America Pharmaceutical | Jynarque | $77 | 4 payments
|
| Amgen | Parsabiv | $25 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $14 | 1 payment
|
2019: $460
| Janssen Pharmaceuticals | Invokana | $224 | 6 payments
|
| Relypsa | Veltassa | $134 | 16 payments
|
| Amgen | Parsabiv | $85 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $18 | 1 payment
|
Professional record
- NPI
- 1083674550
- Licence
- CA AG9500
- Group
- West Coast Kidney · North East Medical Services
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A695000
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2149 E Warner Rd Ste 102, Tempe, AZ, 85284
- NPI first listed
- 2006-03-27
- NPI last updated
- 2019-08-26
This is when the NPI record was last certified, not a medical board exam.